PTU Tablet

About PTU 50 mg Tablet

Renata PLC. manufactures PTU 50 mg Tablet, containing the active ingredient propylthiouracil. This medicine is used in the management of an overactive thyroid gland.

What is PTU 50 mg Tablet?

PTU 50 mg Tablet is a thyroid medicine from Renata PLC. that contains propylthiouracil. It works by reducing the production of thyroid hormones and is used in people with an overactive thyroid (hyperthyroidism). It is typically prescribed when other treatments are not suitable. The medicine is available as a tablet in a 4 x 14 pack. It should only be taken under a doctor's supervision, as regular monitoring is needed. The doctor will determine the appropriate dose and duration of treatment for each patient.

Uses of PTU

PTU 50 mg Tablet is used to treat hyperthyroidism in conditions such as Graves' disease or toxic multinodular goiter. It is prescribed for patients who cannot tolerate another antithyroid medicine and for whom surgery or radioactive iodine is not an option. It is also used to relieve symptoms before thyroid surgery or radioactive iodine therapy. Your doctor will decide if this medicine is right for you.

How to use PTU

Take PTU 50 mg Tablet exactly as your doctor prescribes. Swallow the tablet with water, with or without food. The dose and how often you take it will be set by your doctor based on your condition. Do not change the dose or stop taking the medicine without consulting your doctor. If you miss a dose, ask your doctor or pharmacist for advice on what to do.

Side effects of PTU

Common side effects of PTU 50 mg Tablet include nausea, vomiting, headache, muscle or joint pain, stomach pain, sleepiness, dizziness, itching or tingling, swelling, changes in taste, and hair loss. Some people may have an enlarged salivary gland or lymph node. Contact your doctor right away if you notice signs of liver problems (such as yellowing of the skin or eyes, dark urine, or pale stools) or a sore throat, fever, or skin rash.

Safety and precautions

PTU 50 mg Tablet is not for anyone with a known allergy to propylthiouracil or any ingredient in the product. It carries a risk of liver injury, so tell your doctor immediately if you develop symptoms like nausea, itching, jaundice, dark urine, or abdominal pain, especially in the first months of treatment. This medicine is in pregnancy category D and may harm the unborn baby; it should be used during pregnancy only if the doctor decides it is necessary. Discuss pregnancy, breastfeeding, and all other medicines with your doctor before starting treatment.

Frequently asked questions

What is PTU 50 mg Tablet used for and what kind of medicine is it?

PTU 50 mg Tablet is an antithyroid medicine. It is used to treat an overactive thyroid (hyperthyroidism) in conditions like Graves' disease, and to prepare patients for thyroid surgery or radioactive iodine therapy. It works by reducing the amount of thyroid hormone your body makes.

Who should avoid PTU 50 mg Tablet or ask the doctor first?

Do not take this medicine if you are allergic to propylthiouracil or any of its ingredients. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding, or if you have liver problems. The doctor will decide whether this medicine is safe for you.

What side effects should I watch for and when should I call the doctor?

Common side effects include nausea, headache, muscle pain, dizziness, and hair loss. Call your doctor right away if you have yellowing of the skin or eyes, dark urine, pale stools, stomach pain, sore throat, fever, or a skin rash, as these may be signs of a serious problem.

What is the price of PTU 50 mg Tablet?

The listed price is ৳ 10.00. For the most up-to-date price and availability, please check with your pharmacy or the website.

Indications

Propylthiouracil is indicated:
  • in patients with Graves' disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option
  • to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole

Pharmacology

Propylthiouracil inhibits the synthesis of thyroid hormones and thus is effective in the treatment of hyperthyroidism. The drug does not inactivate existing thyroxine and triiodothyronine that are stored in the thyroid or circulating in the blood, nor does it interfere with the effectiveness of thyroid hormones given by mouth or by injection. Propylthiouracil inhibits the conversion of thyroxine to triiodothyronine in peripheral tissues and may therefore be an effective treatment for thyroid storm. Propylthiouracil is readily absorbed and is extensively metabolized. Approximately 35% of the drug is excreted in the urine, in intact and conjugated forms, within 24 hours.

Dosage & Administration

Adults: The initial dose is 300 mg daily. In patients with severe hyperthyroidism, very large goiters, or both, the initial dose may be increased to 400 mg daily; an occasional patient will require 600 to 900 mg daily initially. The usual maintenance dose is 100 to 150 mg daily.

Pediatric Patients: Propylthiouracil is generally not recommended for use in the pediatric patient population except in rare instances in which other alternative therapies are not appropriate options. Studies evaluating appropriate dosing regimen have not been conducted in the pediatric population although general practice would suggest initiation of therapy in patients 6 years or older at a dosage of 50 mg daily with careful upward titration based on clinical response and evaluation of TSH and free T4 levels. Although cases of severe liver injury have been reported with doses as low as 50 mg/day, most cases were associated with doses of 300 mg/day and higher.

Interaction

Anticoagulants (oral): Due to the potential inhibition of vitamin K activity by propylthiouracil, the activity of oral anticoagulants (e.g., warfarin) may be increased; additional monitoring of PT/INR should be considered, especially before surgical procedures.

Beta-adrenergic blocking agents: Hyperthyroidism may cause an increased clearance of beta blockers with a high extraction ratio. A reduced dose of beta-adrenergic blockers may be needed when a hyperthyroid patient becomes euthyroid.

Digitalis glycosides: Serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid; a reduced dose of digitalis glycosides may be needed.

Theophylline: Theophylline clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid; a reduced dose of theophylline may be needed.

Contraindications

Propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

Side Effects

The most common side effects of Propylthiouracil include:
  • nausea
  • muscle pain
  • vomiting
  • headache
  • upper stomach pain or tenderness
  • sleepiness
  • joint pain
  • nerve pain
  • itching or tingling
  • swelling (edema)
  • loss or change in taste
  • dizziness
  • loss of hair
  • enlarged salivary glands or enlarged lymph node

Pregnancy & Lactation

Pregnancy Category D. There are cases of liver injury, including liver failure and death, in women treated with propylthiouracil during pregnancy. Two reports of in utero exposure with liver failure and death of a newborn have been reported. If propylthiouracil is used during pregnancy, or if the patient becomes pregnant while taking propylthiouracil, the patient should be warned of the rare potential hazard to the mother and fetus of liver damage. Propylthiouracil crosses the placenta and can cause fetal goiter and cretinism when administered to a pregnant woman. After the first trimester of pregnancy, the use of an alternative antithyroid medication may be advisable.

Nursing Mothers: Propylthiouracil is present in breast milk to a small extent and therefore likely results in clinically insignificant doses to the nursing infant. In one study, nine lactating women were administered 400 mg of propylthiouracil by mouth. The mean amount of propylthiouracil excreted during 4 hours after drug administration was 0.025% of the administered dose.

Precautions & Warnings

Patients should be instructed to report any symptoms of hepatic dysfunction (anorexia, pruritus, jaundice, light colored stools, dark urine, right upper quadrant pain, etc.), particularly in the first six months of therapy. When these symptoms occur, measurement should be made of liver function (bilirubin, alkaline phosphatase) and hepatocellular integrity (ALT/AST levels). Patients who receive propylthiouracil should be under close surveillance and should be counseled regarding the necessity of immediately reporting any evidence of illness, particularly sore throat, skin eruptions, fever, headache, or general malaise. In such cases, white blood cell and differential counts should be obtained to determine whether agranulocytosis has developed. Particular care should be exercised with patients who are receiving concomitant drugs known to be associated with agranulocytosis.

Overdose Effects

Symptoms: Nausea, vomiting, epigastric distress, headache, fever, arthralgia, pruritus, edema, and pancytopenia. Agranulocytosis is the most serious effect. Rarely, exfoliative dermatitis, hepatitis, neuropathies or CNS stimulation or depression may occur. No information is available on the following: LD 50 ; concentration of propylthiouracil in biologic fluids associated with toxicity and/or death; the amount of drug in a single dose usually associated with symptoms of overdosage; or the amount of propylthiouracil in a single dose likely to be life-threatening.

Treatment: To obtain up-to-date information about the treatment of overdose, a good resource is the certified Regional Poison Control Center. In managing overdosage, consider the possibility of multiple drug overdoses, interaction among drugs, and unusual drug kinetics in the patient. In the event of an overdose, appropriate supportive treatment should be initiated as dictated by the patient’s medical status.

Storage Conditions

Store at controlled room temperature 15°-30°C

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.